121 related articles for article (PubMed ID: 28704324)
1. Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma.
Richmond AM; Blake EA; Torkko K; Smith EE; Spillman MA; Post MD
Int J Gynecol Cancer; 2017 Nov; 27(9):1895-1903. PubMed ID: 28704324
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor 1 protein and estrogen receptor beta expression are associated with poor outcomes in uterine carcinosarcoma.
Guntupalli SR; Cao D; Shroff R; Gao F; Menias C; Stewart Massad L; Powell MA; Mutch DG; Thaker PH
Ann Surg Oncol; 2013 Jul; 20(7):2373-9. PubMed ID: 23344579
[TBL] [Abstract][Full Text] [Related]
3. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course.
Yoder BJ; Tso E; Skacel M; Pettay J; Tarr S; Budd T; Tubbs RR; Adams JC; Hicks DG
Clin Cancer Res; 2005 Jan; 11(1):186-92. PubMed ID: 15671545
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
Etoh T; Nakai H
J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
[TBL] [Abstract][Full Text] [Related]
5. L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition.
Versluis M; Plat A; de Bruyn M; Matias-Guiu X; Trovic J; Krakstad C; Nijman HW; Bosse T; de Bock GH; Hollema H
Virchows Arch; 2018 Nov; 473(5):591-598. PubMed ID: 30140948
[TBL] [Abstract][Full Text] [Related]
6. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
[No Abstract] [Full Text] [Related]
7. Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer.
Daponte A; Kostopoulou E; Papandreou CN; Daliani DD; Minas M; Koukoulis G; Messinis IE
Anticancer Res; 2008; 28(3B):1905-10. PubMed ID: 18630479
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
[TBL] [Abstract][Full Text] [Related]
9. Fascin expression in uterine smooth muscle tumors.
Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B
Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
[TBL] [Abstract][Full Text] [Related]
10. AKT, EGFR, C-ErbB-2, and C-kit expression in uterine carcinosarcoma.
Saglam O; Husain S; Toruner G
Int J Gynecol Pathol; 2013 Sep; 32(5):493-500. PubMed ID: 23896716
[TBL] [Abstract][Full Text] [Related]
11. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
12. Nestin: A biomarker of aggressive uterine cancers.
Hope ER; Mhawech-Fauceglia P; Pejovic T; Zahn CM; Wang G; Conrads TP; Larry Maxwell G; Hamilton CA; Darcy KM; Syed V
Gynecol Oncol; 2016 Mar; 140(3):503-11. PubMed ID: 26718725
[TBL] [Abstract][Full Text] [Related]
13. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
14. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
[TBL] [Abstract][Full Text] [Related]
15. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer.
Grothey A; Hashizume R; Sahin AA; McCrea PD
Br J Cancer; 2000 Oct; 83(7):870-3. PubMed ID: 10970687
[TBL] [Abstract][Full Text] [Related]
16. Fascin expression is related to poor survival in gastric cancer.
Kim SJ; Kim DC; Kim MC; Jung GJ; Kim KH; Jang JS; Kwon HC; Kim YM; Jeong JS
Pathol Int; 2012 Dec; 62(12):777-84. PubMed ID: 23252866
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
Won KY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
[TBL] [Abstract][Full Text] [Related]
18. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
19. Fascin expression in undifferentiated and dedifferentiated endometrial carcinoma.
Stewart CJ; Crook ML
Hum Pathol; 2015 Oct; 46(10):1514-20. PubMed ID: 26239622
[TBL] [Abstract][Full Text] [Related]
20. Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.
Huang GS; Arend RC; Li M; Gunter MJ; Chiu LG; Horwitz SB; Goldberg GL
Am J Obstet Gynecol; 2009 Apr; 200(4):457.e1-5. PubMed ID: 19200930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
